GEACellular agricultureGEA to open food biotech pilot-scale facil...GEA has launched its second Food Application and Technology Center (ATC) globally in the US, to target the largest consumer market for cellular agriculture. The facility features advanced bioreactors … more ➔
Max-Planck SocietyObesityThe smell of food makes you feel fullLose weight without expensive obesity pills? The discovery of a direct link between olfactory receptors and areas of the brain that signal satiety makes this seem possible, initially in mice. more ➔
adobe stock - trinsetFinancingSpliceBio SL secures US$135m in Series B f...SpliceBio SL has baged US$135m in a Series B financing co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors The Barcelona-based … more ➔
adobe stock.com - EtiAmmos FinancingMosanna Therapeutics bags $80m in Series A...Obstructive sleep apnea (OSA) specialist Mosanna Therapeutics AG has secured US$80m in a Series A financing to fund clinical testing through Phase II of its nasal OSA spray MOS118. more ➔
BIO-CATGene and cell therapiesSpanish BIO-CAT cluster starts new ATMP ac...The Spanish BIO-CAT cluster has launched a new accelerator called ATMP Catalyst, which will support six preclinical gene and cell therapy projects per year in each of three annual calls to support translation … more ➔
Frederick BernasBioeconomyBig deal: Amphistar goes transatlanticBelgian micriobial fermentation specialist AmphiStar NV has partnered with US plant-based ingredient heavyweight Kensing to market its biosurfactants in the US, using locally-produced feedstocks. Amphistar’s … more ➔
EFPIARegulationPharma industry calls EU pharma package co...Pharmaceutical associations have responded with sharp criticism to the adoption of the revised general pharmaceutical legislation by the EU Council of Ministers in the form of a directive and a regulation. … more ➔
Bristol Myers SquibbPartnershipsSuper deal for BioNTech – BMS licenses p...In the race to replace MSD’s mega blockbuster pembrolizumab with a more effective bispecific VEGF x PD-(L)1 antibody, German company BioNTech SE has struck a good deal. BioNTech is now developing its … more ➔
Invest in Scotland, FlexBioEngineering biologyScotland’s bioeconomy gets scale-up boos...Scotland’s biotechnology sector is celebrating a major milestone with the launch of the nation’s first open-access 300-litre fermenter – a state-of-the-art piece of equipment that will support … more ➔
MichaelVi - stock.adobe.comColorectal cancerScientists uncover target to stop colitis-...German researchers have identified a promising new target to stop the inflammatory response in ulcerative colitis—a breakthrough that could help prevent the progression to colorectal cancer. Phase … more ➔